Skip to main content

Patient Support Line 1-866-433-8000, Monday - Friday: 8:00 AM to 8:00 PM ET

Starting treatment for HR+,HER2- metastatic breast cancer. More life for living.
With KISQALI, you can live longer, so you can spend more time doing what you love*
*Time spent living with breast cancer is called overall survival, or OS, in clinical trials. Median OS is the length of time when half of the people in the trial were still alive. At an 80-month check-in, median OS was 63.9 months with KISQALI + an AI vs 51.4 months with placebo + an AI.